The weight-loss drug market, now exceeding $100 billion, is rapidly expanding. Join industry leaders for a brand-new virtual event focused on the opportunities and challenges of this booming industry.

While the market boom in weight loss drugs presents enormous financial opportunities for life sciences companies, it also carries substantial legal, regulatory, and reimbursement risks. With political shifts potentially impacting Medicare/Medicaid, new leadership at the FDA increasing compliance pressure, and new entrants to the market compounding existing litigation and market share exclusivity risks, knowing where you stand in relation to your peers is imperative.

Key Event Highlights

Regulatory Compliance & Market Strategies
Navigating FDA, FTC, and CMS oversight under a new administration.

Intellectual Property & Exclusivity Risks
Understanding how patent cliffs and biosimilar competition could reshape the market.

Compounding & Telehealth Disruption
Examining regulatory battles over compounded GLP-1 drugs and their impact on traditional pharma.

Reimbursement & Payer Strategies
Addressing insurer pushback, Medicare drug pricing negotiations, and PBM (pharmacy benefit manager) strategies.

Litigation & Liability Risks
Preparing for mass tort risks, product liability concerns, and class action lawsuits.

Investment & Strategic Deals
Exploring M&A trends, venture capital outlook, and the licensing models influencing the future of weight loss pharmaceuticals.

Questions?

Email us at [email protected]

Get in Touch

Ready to Register?

Secure your space now.

Register Now